Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
New words:
added, Advisory, aged, aggregate, aging, Arizton, Ashely, biggest, blue, board, cardiovascular, Chan, child, debt, Defi, elderly, experience, eyed, Harmony, healthy, Hei, Hong, income, injury, instruction, Intelligence, issuance, Kingdom, KLN, Kong, Lau, left, Leong, Liao, living, longer, method, musculoskeletal, neurological, open, option, patient, permanent, physiotherapy, Po, poluation, populated, population, postpartum, premium, prevention, prior, priority, recovery, rehabilitation, replaced, reversed, Road, role, sea, seeking, serve, Sha, share, speed, stream, suitable, TA, tap, therapy, treatment, trend, Tsim, Tsui, underlying, unrelated, Wenqiu
Removed:
accounted, America, application, attributed, begun, boost, building, community, compound, cost, Datamonitor, delivery, determined, device, diagnosed, domiciled, drug, East, fastest, FDA, geography, growing, high, home, importance, increasing, India, injectable, injector, insulin, introduction, key, largest, leading, marketplace, Middle, million, North, observed, OEM, Pacific, people, pharmaceutical, phobia, preparing, prescription, public, quickly, range, rate, region, segment, standby, stick, technology, undiscovered, untapped, update, updated, USA, USD, vaccination, version, wide
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view